Case Summary:

With a Ph.D. in cardiovascular biology, an assistant staff scientist from India hired us to construct an EB-1A (Alien of Extraordinary Ability) petition on his behalf. We evaluated his credentials, a record of his noteworthy successes in the field of cardiovascular pharmacology. We reviewed his research focusing on clarifying the cellular mechanisms and therapeutic capacity of thioredoxin, addressing some of our nation’s and the world’s most pressing issues, including the medical field’s ability to prevent and treat prevalent conditions such as hypertension and cardiovascular disease. Therefore, we agreed to lead him to accomplish the EB1A approval to move further in securing his green card.

We gathered informative bits from his credentials to add in his petition packet to confirm how he has made original contributions of major significance to the field of cardiovascular pharmacology.

• We discerned that his concrete background in cardiovascular biology, biochemistry, and molecular biology has allowed his research to be original, resulting in his success in fundamentally transforming cardiovascular disease mechanisms research. In addition, we recorded the 16 peer-reviewed scientific articles he published which accumulated 430 citations, which is widely understood to be an objective measure of a researcher’s influence within their area of expertise. By this citation record gathered from other experts from at least 47 countries, it is evident that our client has established himself as a top-notch scientist in the field of cardiovascular pharmacology.
• Besides, we detailed his peer-review participation as he completed 17 reviews for highly acclaimed journals. Also, he has not only been recruited into normal peer review positions but advisory and editorial board roles as well, which demonstrates the value of his leadership to the field. This is yet more evidence that he is an exemplary researcher in his area of expertise and must continue to be supported in his work.
• Furthermore, we included four recommendation letters in his petition packet from other researchers in the field from remarkable institutions. One of them stated the following:

“There are few researchers as capable of implementing such research and producing these findings as [client]. This is why it is imperative to ensure that he specifically can keep contributing to the field … his talents in designing experiments and biomedical research solutions make him a rare scientist worth supporting. His work’s advancements for healthcare alone mean there is much to be gained from his ongoing work.”

We, successfully, proved to USCIS that our client’s work on pharmacological interventions using signaling pathways for a range of health conditions, making it vital to public health. Therefore, his intended research goals were granted the EB1A approval in just 8 days. We thank our team and the Premium Processing Service, which is a paid option proffered by the USCIS that allows petitioners to enjoy revved-up adjudication. We thank our client for choosing us for his I-140 petition and for retaining us for his I-485 applications. The best news was acquiring the I-485 approvals 4 months after we filed his cases. We genuinely congratulate him on this breakthrough.